Insider screener

Period: 12 months Role: 10% owners × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

770 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

770 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

770 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

770 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
770 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
770 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

770 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
22 Dec 2025
Sold on a plan 3×
$1.73M 22,937 at 75.43
0.3%
Planned (10b5-1)
19 Dec 2025
Bought on a plan
$14.18M 204,000 at 69.50
0.4%
Bought on a plan
19 Dec 2025
Sold on a plan
$2.26M 78,619 at 28.78
100%
Sold half or more
19 Dec 2025
Capital V LLC 10% owner
Sold on a plan
$88.43K 7,500 at 11.79
100%
Sold half or more
18 Dec 2025
Bought on a plan
$14.18M 204,350 at 69.38
0.4%
Bought on a plan
18 Dec 2025
Sold on a plan
$2.51M 88,444 at 28.41
100%
Sold half or more
18 Dec 2025
Capital V LLC 10% owner
Sold on a plan
$178.92K 15,000 at 11.93
66.7%
Sold half or more
17 Dec 2025
Capital V LLC 10% owner
Sold on a plan
$176.05K 15,000 at 11.74
40.0%
Planned (10b5-1)
17 Dec 2025
Sold on a plan
$27.00K 25,000 at 1.08
11.1%
Planned (10b5-1)
16 Dec 2025
DUFFIELD DAVID A 10% owner
Sold on a plan 4×
$17.59M 81,434 at 215.98
43.7%
Planned (10b5-1)
16 Dec 2025
Sold on a plan 3×
$2.09M 27,116 at 77.06
0.4%
Planned (10b5-1)
16 Dec 2025
Sold on a plan
$26.00K 25,000 at 1.04
10.0%
Planned (10b5-1)
15 Dec 2025
Sold on a plan
$3.06M 39,384 at 77.63
0.6%
Planned (10b5-1)
15 Dec 2025
Sold on a plan
$40.00K 50,000 at 0.80
0.7%
Planned (10b5-1)
10 Dec 2025
Sold on a plan
$27.25K 25,000 at 1.09
33.3%
Planned (10b5-1)
9 Dec 2025
Sold on a plan
$27.75K 25,000 at 1.11
25.0%
Planned (10b5-1)
8 Dec 2025
Bayview Legacy, LLC 10% owner · indirect
Sold on a plan
$1.24M 70,000 at 17.71
0.7%
Planned (10b5-1)
8 Dec 2025
Sold on a plan
$37.00K 50,000 at 0.74
0.7%
Planned (10b5-1)
5 Dec 2025
Bayview Legacy, LLC 10% owner · indirect
Sold on a plan
$1.02M 60,000 at 17.08
0.6%
Planned (10b5-1)
4 Dec 2025
Sold on a plan
$1.08M 41,563 at 26.02
100%
Sold half or more
4 Dec 2025
Bayview Legacy, LLC 10% owner · indirect
Sold on a plan
$658.47K 40,000 at 16.46
0.4%
Planned (10b5-1)
4 Dec 2025
GADICKE ANSBERT Former 10% Owner · indirect
Sold on a plan
$80.73K 83,230 at 0.97
1.7%
Planned (10b5-1)
4 Dec 2025
MPM BioVentures 2014, L.P. Former 10% Owner · indirect
Sold on a plan
$80.73K 83,230 at 0.97
1.7%
Planned (10b5-1)
3 Dec 2025
Sold on a plan 2×
$3.04M 114,024 at 26.67
100%
Sold half or more
3 Dec 2025
GADICKE ANSBERT Former 10% Owner · indirect
Sold on a plan
$49.79K 57,225 at 0.87
1.2%
Planned (10b5-1)
3 Dec 2025
MPM BioVentures 2014, L.P. Former 10% Owner · indirect
Sold on a plan
$49.79K 57,225 at 0.87
1.2%
Planned (10b5-1)
3 Dec 2025
Sold on a plan
$26.25K 25,000 at 1.05
20.0%
Planned (10b5-1)
2 Dec 2025
DUFFIELD DAVID A 10% owner
Sold on a plan 5×
$17.40M 82,025 at 212.19
43.8%
Planned (10b5-1)
2 Dec 2025
Sold on a plan
$600.56K 23,152 at 25.94
100%
Sold half or more
2 Dec 2025
GADICKE ANSBERT Former 10% Owner · indirect
Sold on a plan
$52.76K 59,277 at 0.89
1.2%
Planned (10b5-1)
2 Dec 2025
MPM BioVentures 2014, L.P. Former 10% Owner · indirect
Sold on a plan
$52.76K 59,277 at 0.89
1.2%
Planned (10b5-1)
2 Dec 2025
Sold on a plan
$26.75K 25,000 at 1.07
14.3%
Planned (10b5-1)
1 Dec 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$1.15M 191,854 at 5.98
1.4%
Planned (10b5-1)
1 Dec 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$57.26K 60,917 at 0.94
1.2%
Planned (10b5-1)
1 Dec 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$57.26K 60,917 at 0.94
1.2%
Planned (10b5-1)
28 Nov 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$396.01K 61,493 at 6.44
0.4%
Planned (10b5-1)
28 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$20.07K 20,277 at 0.99
0.4%
Planned (10b5-1)
28 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$20.07K 20,277 at 0.99
0.4%
Planned (10b5-1)
26 Nov 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$817.65K 127,938 at 6.39
0.9%
Planned (10b5-1)
26 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$59.52K 60,733 at 0.98
1.2%
Planned (10b5-1)
26 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$59.52K 60,733 at 0.98
1.2%
Planned (10b5-1)
26 Nov 2025
Sold on a plan
$27.75K 25,000 at 1.11
14.3%
Planned (10b5-1)
25 Nov 2025
Sold on a plan 5×
$57.13M 1,030,527 at 55.44
98.5%
Sold half or more
25 Nov 2025
Sold on a plan 5×
$35.93M 648,089 at 55.44
98.5%
Sold half or more
25 Nov 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$1.51M 235,971 at 6.38
1.6%
Planned (10b5-1)
25 Nov 2025
SANFORD PENNY 10% owner · indirect
Sold on a plan
$1.41M 117,179 at 12.04
0.4%
Planned (10b5-1)
25 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$39.13K 42,533 at 0.92
0.8%
Planned (10b5-1)
25 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$39.13K 42,533 at 0.92
0.8%
Planned (10b5-1)
25 Nov 2025
Sold on a plan
$26.75K 25,000 at 1.07
12.5%
Planned (10b5-1)
24 Nov 2025
Sold on a plan 3×
$26.93M 504,259 at 53.41
32.5%
Planned (10b5-1)
Showing 651–700 of 770. ← Newer Page 14 of 16 Older →